Next 10 |
2024-05-07 11:35:38 ET A California-based %Biotech company is stealing the show so far during Tuesday’s session after the company reported Q1 2024 earnings after yesterday’s market close. According to a handful of press releases, the company beat EPS estimates by $0.22...
2024-05-07 10:01:47 ET More on Health Care Select Sector SPDR XLV: Pivotal Week Of Earnings For Healthcare Stocks XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance 16 out...
SAN FRANCISCO, May 07, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the company’s management will participate in the following investor conferences: Bank of America Health Care Conference Format: 1x1 investor meetings Date: Tuesday, May 14,...
2024-05-06 22:31:06 ET FibroGen, Inc. (FGEN) Q1 2024 Earnings Conference Call May 6, 2024 05:00 PM ET Company Participants David DeLucia - VP, Corporate FP&A and IR Thane Wettig - CEO Deyaa Adib - CMO Juan Graham - CFO Chris Chung - SVP, China Operati...
2024-05-06 16:07:17 ET More on FibroGen FibroGen, Inc. 2023 Q4 - Results - Earnings Call Presentation FibroGen, Inc. (FGEN) Q4 2023 Earnings Call Transcript FibroGen falls after early-stage data for prostate cancer drug AstraZeneca returns right to roxadustat...
Topline data from the Pancreatic Cancer Action Network (PanCAN) Precision Promise SM Phase 2/3 study in metastatic pancreatic cancer anticipated in mid-2024 Topline data from LAPIS Phase 3 study in locally advanced unresectable pancreatic cancer anticipated in ...
PRA Group Inc. (PRAA) is expected to report $-0.15 for Q1 2024 Bowman Consulting Group Ltd. (BWMN) is expected to report $-0.04 for Q1 2024 Noble Corporation plc A (NE) is expected to report $0.56 for Q1 2024 Velo3D Inc. (VLD) is expected to report for Q3 2024 Axon Enterprise Inc....
2024-05-03 17:20:20 ET More on FibroGen FibroGen, Inc. 2023 Q4 - Results - Earnings Call Presentation FibroGen, Inc. (FGEN) Q4 2023 Earnings Call Transcript FibroGen falls after early-stage data for prostate cancer drug AstraZeneca returns right to roxadustat...
2024-05-03 15:00:00 ET More on the markets My Current View Of The Market: May 2024 Edition (Technical Analysis) SPY: The 'Value' From Equities Is Historically Low SPY: The Setup Looks Extremely Bearish 'Sell in May and go away': Does it apply in 2024? ...
SAN FRANCISCO, April 29, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) will announce first quarter 2024 financial results on Monday, May 6 after the market close. FibroGen will also conduct a conference call on that day at 5:00 PM Eastern Time with the investment community to further det...
News, Short Squeeze, Breakout and More Instantly...
Shares of Beyond, Inc. (NYSE:BYON) fell sharply during Tuesday’s session following weaker-than-expected quarterly results. Beyond posted adj...
FibroGen, Inc. (NASDAQ:FGEN) shares are trading higher Tuesday after the company posted mixed first-quarter financial results. Here's a look a...
U.S. stocks were higher, with the Dow Jones gaining over 80 points on Tuesday. Shares of Tempur Sealy International, Inc. (NYSE:TPX) rose sharply d...